Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.
This study examines structural changes in specific thalamic regions among patients with Parkinson's disease dementia using advanced neuroimaging analysis. Machine learning algorithms are applied to these volumetric measurements to develop predictive models for diagnosis and disease severity assessment.
GLP-1 receptor agonists, originally developed for diabetes and obesity, show neuroprotective properties in preclinical models of movement disorders by modulating neuroinflammation, oxidative stress, and protein aggregation. Clinical evidence is most advanced in Parkinson's disease, though early promise from exenatide and lixisenatide trials was not confirmed in larger phase III studies, with preliminary signals emerging in other movement disorders.
This PET neuroimaging study examined cholinergic terminal density in 16 patients with isolated REM sleep behavior disorder (iRBD, a prodromal stage of Parkinson's disease) compared to 12 Parkinson's patients and 18 controls. Both patient groups showed similar cortical cholinergic denervation (11-12% reduction) with distinct regional patterns, while iRBD showed associations between lower cholinergic uptake and impaired executive/visuospatial function.
Official clinical guidance from the Movement Disorder Society providing an evidence-based biological definition, staging system, and classification framework for Parkinson's disease. This statement establishes standardized diagnostic and prognostic criteria for specialists managing the condition.
This longitudinal study tracked 258 newly diagnosed Parkinson's disease patients over five years, identifying three cognitive trajectory groups: cognitively normal, remitting decline, and progressive decline. Progressive cognitive decline was associated with depression, REM sleep behavior disorder, older age, lower education, elevated neurofilament biomarkers, and accelerated hippocampal volume loss, while remitting decline showed intermediate outcomes and olfactory dysfunction.